In this expert roundtable, three highly experienced industry professionals discuss the importance and nuances of phase-appropriate analytical control in early-stage cell therapy development. The panelists share insights on key areas of innovation such as automated solutions, digital PCR, and next-generation sequencing, and share their advice on early engagement with regulatory agencies to help ensure successful outcomes in getting cell therapies to patients.